FDA Leaders’ Public Health Fundamentals Offer Hope To Sponsors
This article was originally published in The Tan Sheet
Executive Summary
FDA wants to be judged on its overall impact on public health - not on drug approvals - Commissioner Peggy Hamburg and Principal Deputy Josh Sharfstein say in the New England Journal of Medicine
You may also be interested in...
Commissioner Hamburg: Moving FDA Beyond A Regulatory Agency
Of the leading candidates for FDA commissioner in the Obama administration, Margaret Hamburg seemed among those with the least relevant experience -- an illustrious career to be sure, but one that lacked a decision-making role involving medical products
Commissioner Hamburg: Moving FDA Beyond A Regulatory Agency
Of the leading candidates for FDA commissioner in the Obama administration, Margaret Hamburg seemed among those with the least relevant experience -- an illustrious career to be sure, but one that lacked a decision-making role involving medical products
Commissioner Hamburg: Moving FDA Beyond A Regulatory Agency
Of the leading candidates for FDA commissioner in the Obama administration, Margaret Hamburg seemed among those with the least relevant experience -- an illustrious career to be sure, but one that lacked a decision-making role involving medical products